Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp ZOM

Healthcare Medical Devices
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic... see more

Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues

Accesswire August 15, 2022

Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference

Newsfile August 9, 2022

Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health

Accesswire July 18, 2022

Zomedica Announces New Global Manufacturing & Distribution Center

Accesswire July 7, 2022

Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

Accesswire July 6, 2022

Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team

Accesswire June 28, 2022

Zomedica to Participate in Panel Discussion at Animal Health Investment Forum

Accesswire June 21, 2022

Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared

Accesswire June 15, 2022

Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses

Accesswire June 13, 2022

Zomedica to Present at JMP Securities Life Sciences Conference

Accesswire June 8, 2022

Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary

Accesswire June 2, 2022

Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line

Accesswire May 19, 2022

Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.

Accesswire May 18, 2022

Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans

Accesswire May 16, 2022

Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues

Accesswire May 10, 2022

Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship

Accesswire May 4, 2022

Zomedica to Present at H.C. Wainwright Global Investment Conference

Accesswire April 27, 2022

Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association

Accesswire April 13, 2022

Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform

Accesswire April 4, 2022

Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results

Accesswire March 1, 2022